BFA
UTHR icon

BlackRock Fund Advisors’s United Therapeutics UTHR Stock Holding History

BlackRock Fund Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$341M Buy
2,376,204
+102,788
+5% +$13.1M 0.06% 332
2016
Q3 		$268M Buy
2,273,416
+55,447
+2% +$6.66M 0.06% 400
2016
Q2 		$235M Buy
2,217,969
+59,026
+3% +$6.58M 0.05% 418
2016
Q1 		$241M Buy
2,158,943
+35,288
+2% +$4.47M 0.06% 392
2015
Q4 		$333M Sell
2,123,655
-48,341
-2% -$7.04M 0.08% 259
2015
Q3 		$285M Buy
2,171,996
+48,864
+2% +$7.84M 0.07% 274
2015
Q2 		$369M Buy
2,123,132
+105,561
+5% +$19M 0.09% 214
2015
Q1 		$348M Buy
2,017,571
+45,778
+2% +$6.98M 0.08% 236
2014
Q4 		$255M Sell
1,971,793
-33,280
-2% -$4.29M 0.06% 334
2014
Q3 		$258M Buy
2,005,073
+82,884
+4% +$8.54M 0.07% 285
2014
Q2 		$170M Sell
1,922,189
-61,334
-3% -$5.9M 0.05% 489
2014
Q1 		$187M Sell
1,983,523
-5,995
-0.3% -$613K 0.06% 411
2013
Q4 		$225M Buy
1,989,518
+141,028
+8% +$12.7M 0.07% 317
2013
Q3 		$146M Buy
1,848,490
+145,102
+9% +$10.6M 0.05% 483
2013
Q2 		$112M Buy
+1,703,388
New +$110M 0.04% 585

Other funds holding UTHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BlackRock Fund Advisors's UTHR Position: Q4 2016 in Review

BlackRock Fund Advisors increased its United Therapeutics (UTHR) stake by 4.5% in Q4 2016, buying an estimated $13.1M and bringing the position to 2,376,204 shares worth $341M. The position accounts for 0.06% of the portfolio, ranked #332.

BlackRock Fund Advisors first reported a position in UTHR in Q2 2013 and has held it in 15 quarters since. The position peaked at $369M in Q2 2015. 406 funds tracked by Wall St. Rank hold UTHR as of Q4 2016.

  • BlackRock Fund Advisors held 2,376,204 shares of United Therapeutics worth $341M as of Q4 2016.
  • BlackRock Fund Advisors bought 102,788 United Therapeutics shares in Q4 2016, an estimated $13.1M.
  • United Therapeutics made up 0.06% of BlackRock Fund Advisors's portfolio in Q4 2016, its #332 holding.
  • BlackRock Fund Advisors first reported a position in United Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's United Therapeutics position peaked at $369M in Q2 2015.
  • 406 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.